HER2 testing in the UK: Recommendations for breast and gastric in-situ hybridisation methods

John M S Bartlett, J. Starczynski, Neil Atkey, E. Kay, A. O'Grady, Michael Gandy, Merdol Ibrahim, Bharat Jasani, I. O. Ellis, S. E. Pinder, R. A. Walker

Research output: Contribution to journalReview articlepeer-review

56 Citations (Scopus)

Abstract

These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.

Original languageEnglish
Pages (from-to)649-653
Number of pages5
JournalJournal of clinical pathology
Volume64
Issue number8
DOIs
Publication statusPublished - Aug 2011
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'HER2 testing in the UK: Recommendations for breast and gastric in-situ hybridisation methods'. Together they form a unique fingerprint.

Cite this